LW Moreland, MH Schiff, SW Baumgartner, EA … - Ann Intern Med, 1999 - Am Coll Physicians Larry W. Moreland, MD; Michael H. Schiff, MD; Scott W. Baumgartner, MD;
Elizabeth A. Tindall, MD; Roy M. Fleischmann, MD; Ken J. Bulpitt, MD; Arthur L.
Weaver, MD; Edward C. Keystone, MD; Daniel E. Furst, MD; Philip J. Mease, ... Cited by 1071 - Related articles - BL Direct - All 4 versions
ME Weinblatt, JM Kremer, AD Bankhurst, KJ … - The New England journal of medicine, 1999 - nejm.highwire.org Results The addition of etanercept to methotrexate therapy resulted in rapid and
sustained improvement. At 24 weeks, 71 percent of the patients receiving
etanercept plus methotrexate and 27 percent of those receiving placebo plus ... Cited by 1316 - Related articles - BL Direct - All 6 versions
- ►stanford.edu [PDF] JM Bathon, RW Martin, RM Fleischmann, JR … - The New England journal of medicine, 2000 - nejm.highwire.org Methods We treated 632 patients with early rheumatoid arthritis with either
twice-weekly subcutaneous etanercept (10 or 25 mg) or weekly oral methotrexate
(mean, 19 mg per week) for 12 months. Clinical response was defined as the ... Cited by 1198 - Related articles - BL Direct - All 11 versions
- ►thelancet.com R Maini, EW St Clair, F Breedveld, D Furst, … - The Lancet, 1999 - Elsevier At 30 weeks, the American College of Rheumatology (20) response criteria,
representing a 20% improvement from baseline, were achieved in 53, 50, 58, and
52% of patients receiving 3 mg/kg every 4 or 8 weeks or 10 mg/kg every 4 or ... Cited by 1336 - Related articles - BL Direct - All 5 versions
ME Weinblatt, EC Keystone, DE Furst, LW … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 823 - Related articles - BL Direct - All 5 versions
- ►sepeap.es [PDF] LW Moreland, SW Baumgartner, MH Schiff, EA … - New England Journal of Medicine, 1997 - content.nejm.org Results Treatment with TNFR:Fc led to significant reductions in disease
activity, and the therapeutic effects of TNFR:Fc were dose-related. At three
months, 75 percent of the patients in the group assigned to 16 mg of ... Cited by 1205 - Related articles - BL Direct - All 8 versions
PE Lipsky, DMFM van der Heijde, EW St Clair … - The New England journal of medicine, 2000 - nejm.highwire.org INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS ... P ETER
E. L IPSKY , MD, D ESIREE MFM VAN DER H EIJDE , MD, E. W ILLIAM S T . C LAIR ,
MD, D ANIEL E. F URST , MD, ... F ERDINAND C. B REEDVELD , MD, J OACHIM ... Cited by 1753 - Related articles - BL Direct - All 7 versions
RN Maini, FC Breedveld, JR Kalden, JS Smolen … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 940 - Related articles - BL Direct - All 4 versions
MC Genovese, JM Bathon, RW Martin, RM … - Arthritis Rheum, 2002 - aramis.stanford.edu Mark C. Genovese,1 Joan M. Bathon,2 Richard W. Martin,3 Roy M. Fleischmann,4
John R. Tesser,5 Michael H. Schiff,6 Edward C. Keystone,7 Mary Chester Wasko,8
Larry W. Moreland,9 Arthur L. Weaver,10 Joseph Markenson,11 Grant W. ... Cited by 501 - Related articles - View as HTML - BL Direct - All 9 versions
- ►sepeap.org [PDF] L Klareskog, D van der Heijde, JP de Jager, … - The Lancet, 2004 - Elsevier Methods In a double-blind, randomised, clinical efficacy, safety, and
radiographic study, 686 patients with active rheumatoid arthritis were randomly
allocated to treatment with etanercept 25 mg (subcutaneously twice a week), ... Cited by 632 - Related articles - All 9 versions
